# European Journal of Neurology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/european-journal-of-neurology/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 4,940 |
| Citations | 302,411 |
| h-index | 181 |
| Homepage | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1468-1331 |
| Open Access | true |
| ISSN-L | 1351-5101 |
| ISSNs | 1351-5101,1468-1331 |
| OpenAlex ID | https://openalex.org/S162635963 |
| Publisher | Wiley |
| Works | 10,818 |

## Journal papers

Showing 12 of 60.

- [The economic cost of brain disorders in Europe](https://scholariq.org/papers/the-economic-cost-of-brain-disorders-in-europe/)
- [EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force](https://scholariq.org/papers/efns-guidelines-on-the-clinical-management-of-amyotrophic-lateral-sclerosis-mals/)
- [AAN‐EFNS guidelines on trigeminal neuralgia management](https://scholariq.org/papers/aan-efns-guidelines-on-trigeminal-neuralgia-management/)
- [EFNS guidelines on neurostimulation therapy for neuropathic pain](https://scholariq.org/papers/efns-guidelines-on-neurostimulation-therapy-for-neuropathic-pain/)
- [EFNS guidelines on neuropathic pain assessment: revised 2009](https://scholariq.org/papers/efns-guidelines-on-neuropathic-pain-assessment-revised-2009/)
- [<scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> recommendations for the diagnosis of <scp>P</scp>arkinson's disease](https://scholariq.org/papers/scp-efns-scp-scp-mds-scp-scp-es-scp-recommendations-for-the-diagnosis-of-scp-p/)
- [A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex<sup>®</sup>), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis](https://scholariq.org/papers/a-randomized-double-blind-placebo-controlled-parallel-group-enriched-design/)
- [Does caffeine intake protect from Alzheimer's disease?](https://scholariq.org/papers/does-caffeine-intake-protect-from-alzheimer-s-disease/)
- [Summary of the recommendations of the <scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> review on therapeutic management of <scp>P</scp>arkinson's disease](https://scholariq.org/papers/summary-of-the-recommendations-of-the-scp-efns-scp-scp-mds-scp-scp-es-scp-review/)
- [Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force](https://scholariq.org/papers/guidelines-on-routine-cerebrospinal-fluid-analysis-report-from-an-efns-task/)
- [EFNS guidelines on cognitive rehabilitation: report of an EFNS task force](https://scholariq.org/papers/efns-guidelines-on-cognitive-rehabilitation-report-of-an-efns-task-force/)
- [<scp>EFNS‐ENS</scp> Guidelines on the diagnosis and management of disorders associated with dementia](https://scholariq.org/papers/scp-efns-ens-scp-guidelines-on-the-diagnosis-and-management-of-disorders/)

## Journal top topics

Showing 8 of 25.

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.